SK283506B6 - Pyrazolo(3,4-d)pyrimidín, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom a použitie tejto zlúčeniny - Google Patents

Pyrazolo(3,4-d)pyrimidín, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom a použitie tejto zlúčeniny Download PDF

Info

Publication number
SK283506B6
SK283506B6 SK225-2000A SK2252000A SK283506B6 SK 283506 B6 SK283506 B6 SK 283506B6 SK 2252000 A SK2252000 A SK 2252000A SK 283506 B6 SK283506 B6 SK 283506B6
Authority
SK
Slovakia
Prior art keywords
pyrazolo
pyrimidin
formula
thione
pyrimidine
Prior art date
Application number
SK225-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK2252000A3 (en
Inventor
Thomas Arnold
Hans-Joachim Lankau
Manfred Menzer
Angelika Rostock
Christine Tober
Klaus Unverferth
Original Assignee
Arzneimittelwerk Dresden Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arzneimittelwerk Dresden Gmbh filed Critical Arzneimittelwerk Dresden Gmbh
Publication of SK2252000A3 publication Critical patent/SK2252000A3/sk
Publication of SK283506B6 publication Critical patent/SK283506B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK225-2000A 1998-06-22 1999-06-04 Pyrazolo(3,4-d)pyrimidín, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom a použitie tejto zlúčeniny SK283506B6 (sk)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19827679A DE19827679A1 (de) 1998-06-22 1998-06-22 Adenosinrezeptoraffine, antikonvulsiv und antiallergisch/antiasthmatisch wirkende Pyrazolo[3,4-d]pyrimidine und Verfahren zu deren Herstellung
CZ2000594A CZ288195B6 (en) 1998-06-22 1999-06-04 Derivative of pyrazolo[3,4-d]pyrimidines exhibiting anticonvulsive a antiallergic/anti-asthmatic activity, process of its preparation and use
PCT/EP1999/003863 WO1999067243A1 (de) 1998-06-22 1999-06-04 Antikonvulsiv und antiallergisch/antiasthmatisch wirkende pyrazolo(3,4-d)pyrimidine
CA002297706A CA2297706A1 (en) 1998-06-22 2000-02-02 Anticonvulsive and antiallergic/anti-asthmatic pyrazolo-(3,4-d)pyrimidines having affinity for the adenosine receptor, and process for their preparation

Publications (2)

Publication Number Publication Date
SK2252000A3 SK2252000A3 (en) 2000-08-14
SK283506B6 true SK283506B6 (sk) 2003-08-05

Family

ID=27171156

Family Applications (1)

Application Number Title Priority Date Filing Date
SK225-2000A SK283506B6 (sk) 1998-06-22 1999-06-04 Pyrazolo(3,4-d)pyrimidín, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom a použitie tejto zlúčeniny

Country Status (26)

Country Link
US (1) US6054460A (es)
EP (1) EP1005471B1 (es)
JP (1) JP2002518499A (es)
CN (1) CN1126753C (es)
AT (1) ATE223412T1 (es)
AU (1) AU748090B2 (es)
BG (1) BG104150A (es)
BR (1) BR9906552A (es)
CA (2) CA2301107A1 (es)
CZ (1) CZ288195B6 (es)
DE (2) DE19827679A1 (es)
DK (1) DK1005471T3 (es)
EA (1) EA002768B1 (es)
ES (1) ES2182541T3 (es)
HU (1) HUP0003783A3 (es)
IL (1) IL134439A0 (es)
NO (1) NO314760B1 (es)
NZ (1) NZ502880A (es)
PL (1) PL338897A1 (es)
PT (1) PT1005471E (es)
RU (1) RU2194050C2 (es)
SK (1) SK283506B6 (es)
TR (1) TR200000473T1 (es)
TW (1) TW449476B (es)
WO (1) WO1999067243A1 (es)
ZA (1) ZA200000742B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10042092A1 (de) * 2000-08-26 2002-03-07 Dresden Arzneimittel Antikonvulsiv wirkende 2,5-Dihydro-pyrazolo(3,4-d)pyrimidin-4-one und Verfahren zu deren Darstellung
WO2012125400A1 (en) * 2011-03-14 2012-09-20 Acorn Biomedical, Inc. Compositions and methods using adenosine a3 receptor antagonists for the treatment of inflammatory eye diseases
CN106749271B (zh) * 2016-12-07 2019-04-05 青岛科技大学 一类[1,2,4]-三氮唑并[1,5-a]嘧啶酮类杂环化合物、其制备方法及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988000192A1 (en) * 1986-06-26 1988-01-14 Warner-Lambert Company 5-SUBSTITUTED PYRAZOLO[4,3-d]PYRIMIDIN-7-ONES
DE19649460A1 (de) * 1996-11-26 1998-05-28 Bayer Ag Neue substituierte Pyrazolderivate

Also Published As

Publication number Publication date
IL134439A0 (en) 2001-04-30
TR200000473T1 (tr) 2000-09-21
WO1999067243A1 (de) 1999-12-29
ES2182541T3 (es) 2003-03-01
EA200000249A1 (ru) 2000-08-28
EA002768B1 (ru) 2002-08-29
PL338897A1 (en) 2000-11-20
HUP0003783A2 (hu) 2001-04-28
NO20000748L (no) 2000-04-07
TW449476B (en) 2001-08-11
BR9906552A (pt) 2000-08-15
AU4605499A (en) 2000-01-10
US6054460A (en) 2000-04-25
HUP0003783A3 (en) 2001-08-28
EP1005471A1 (de) 2000-06-07
SK2252000A3 (en) 2000-08-14
ATE223412T1 (de) 2002-09-15
BG104150A (en) 2000-12-29
NO20000748D0 (no) 2000-02-15
NO314760B1 (no) 2003-05-19
CZ288195B6 (en) 2001-05-16
ZA200000742B (en) 2000-10-27
CA2301107A1 (en) 1999-12-29
JP2002518499A (ja) 2002-06-25
CN1126753C (zh) 2003-11-05
CA2297706A1 (en) 2001-08-02
DE59902538D1 (de) 2002-10-10
EP1005471B1 (de) 2002-09-04
CZ2000594A3 (cs) 2000-10-11
RU2194050C2 (ru) 2002-12-10
PT1005471E (pt) 2003-01-31
CN1275128A (zh) 2000-11-29
DE19827679A1 (de) 1999-12-23
DK1005471T3 (da) 2002-10-14
NZ502880A (en) 2001-12-21
AU748090B2 (en) 2002-05-30

Similar Documents

Publication Publication Date Title
US6545000B1 (en) [1,2,4]triazolo[1,5-c]pyrimidine derivatives
IE60022B1 (en) Novel compounds
DE10238477A1 (de) Neue Purinderivate, deren Herstellung und deren Verwendung als Arzneimittel
EP0565377B1 (en) Therapeutic agents for use in the treatment of Parkinson's Disease
PL200939B1 (pl) Związki [1,5-a]-pirazolo-1,3,5-triazynowe, środek farmaceutyczny i zastosowanie tych związków
EP0608565A1 (en) Pyridopyrimidine derivatives, their production and use
US4613603A (en) Compounds with a nitrogen-containing heterocyclic nucleus, and drugs in which they are present
US6124300A (en) Aryloxy- and arylthio- fused pyridines and pyrimidines and derivatives
JP3116230B2 (ja) 三環式縮合ピリミジン誘導体
JP2000507552A (ja) アリールオキシおよびアリールチオ縮合ピリジン、アリールオキシおよびアリールチオ縮合ピリミジン、およびそれらの誘導体
SK283506B6 (sk) Pyrazolo(3,4-d)pyrimidín, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom a použitie tejto zlúčeniny
KR100350823B1 (ko) 항경련 효과와 항알레르기/항천식 효과를 갖는피라졸로(3,4-ｄ)피리미딘
US7098217B2 (en) 3,7-dihydro-purine-2,6-dione derivatives as CRF receptor ligands
MXPA00001832A (es) Pirazolo (3,4-d) pirimidinas de accion anticonvulsiva y antialergica/antiasmatica
SK279319B6 (sk) 5-(subst.amino)-8-(fenyl alebo subst.fenyl)-3h, 6h
MXPA01002976A (es) Derivados de (1,2,4,)triazolo(1,5-c) pirimidina
US20030186997A1 (en) 2,5-Dihydro-pyrazolo[3,4-d]pyrimidin-4-ones with an anticonsulsive action and methods for producing the same
MXPA98007869A (es) Piridinas y pirimidinas fusionadas con ariloxi yariltio, y derivados de las mismas